Annual Report for the financial year 2025-26

Ref: MHL/Sec&Legal/2026-27/24 July 27, 2026 BSE Limited National Stock Exchange of India Limited Scrip Code: 542650 Scrip Symbol: METROPOLIS Dear Sir/Madam, Sub: Annual Report of the Company for the financial year 2025-26 along with the Notice convening the 26th Annual General Meeting (‘AGM’) In continuation to our letter dated July 24, 2026, intimating the date of 26th AGM of the Company and pursuant to Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), please find attached herewith a copy of Annual Report for the financial year 2025-26 along with the Notice of the 26th AGM scheduled on Tuesday, August 18, 2026 at 10:00 a.m. (IST) through video conferencing. Pursuant to Regulation 36 of the SEBI Listing Regulations, the Annual Report for the financial year 2025-26 along with the Notice of the 26th AGM are being dispatched to all the eligible shareholders by electronic means on the e-mail addresses as registered with the Company/Registrar and Share Transfer Agent/Depository Participant(s). Further, a physical communication is being sent containing the web link and the exact path to access the Annual Report and Notice of the 26th AGM on the Company's website to the shareholders whose e-mail addresses are not registered in the records. The Annual Report for the financial year 2025-26 and Notice of the 26th AGM have also been made available on the website of the Company at www.metropolisindia.com. You are requested to take the above information on record. Thanking you, Yours faithfully, For Metropolis Healthcare Limited Kamlesh C Kulkarni Head – Legal & Secretarial Encl: a/a MAXIMISING CAPABILITIES. AMPLIFYING GROWTH. 2025-26 Annual Report METROPOLIS HEALTHCARE LIMITED About the Report Our Approach to Reporting Value Creation at Metropolis At Metropolis Healthcare Limited We continued to refine our value-creation model to reflect shifts in the (“Metropolis” or “the Company” or diagnostics sector, changing customer expectations, digital transformation, "MHL"), we continue to strengthen and our continued investments in operational excellence. our commitment to high-quality, transparent, and stakeholder-centric This report highlights how Metropolis generates and sustains value through corporate reporting. This Annual the effective use of the six capitals: Report presents an integrated view of our performance and progress for the financial year ended March 31, 2026 (FY 2025-26). It Financial Intellectual Service Human Natural Social & offers a comprehensive lens into Capital Capital Capital Capital Capital Relationship our strategy, business model, Capital governance, risks, and outcomes across financial and non-financial In line with the nature of our diagnostics business, we refer to Manufactured parameters, demonstrating how we Capital as Service Capital, representing our laboratory infrastructure, continue to create sustainable value technology platforms, logistics network, and service delivery capabilities. Our in an evolving healthcare landscape. performance across these capitals illustrates the link between our strategy, resource allocation, and long-term value creation for all stakeholders. Basis of Reporting For the FY 2025-26 reporting cycle, we have further enhanced the depth • Indian Accounting Standards and value creation during the and relevance of our disclosures financial year. • Corporate governance guidelines to reflect the needs of a diverse issued by the National Stock The consolidated financial stakeholder base, shareholders, Exchange (NSE) and Bombay statements have been prepared in patients, partners, regulators, Stock Exchange (BSE) accordance with the applicable Indian employees, and the communities Accounting Standards (Ind AS) and we serve. • SEBI (Listing Obligations and have undergone statutory audit. Disclosure Requirements) Our reporting approach is guided Regulations, 2015, including As part of our ongoing effort to by the principles of connectivity, Business Responsibility and enhance transparency, we have materiality, consistency, Sustainability Reporting (BRSR) expanded certain non-financial comparability, and strategic requirements. Where relevant, we disclosures to provide a clearer view orientation, ensuring that have also considered evolving of our ESG-aligned performance and stakeholders gain meaningful best practices in sustainability key operational metrics. insights into our performance and and integrated reporting to future direction. Assurance strengthen our disclosures. The disclosures presented in this Frameworks and Guidelines Reporting Scope and Boundary report have been reviewed and The contents of this report are The scope of this report covers approved by the Company’s Board of aligned with leading global and Indian the operations of MHL and its Directors and its Committees. reporting frameworks. It has been subsidiaries for FY 2025-26. prepared in accordance with: While the statutory financial It includes both financial and non- statements have undergone external • The International Integrated financial disclosures that reflect the audit, the non-financial information Reporting (<IR>) Framework Company's progress, performance, presented has not been subjected to issued by the IFRS Foundation third-party assurance. • Applicable regulatory Feedback requirements prescribed by the Stakeholder feedback remains central to improving the effectiveness Securities and Exchange Board of of our reporting. We welcome your comments, questions, and India ("SEBI") suggestions, which help us evolve our approach year after year. • The Companies Act, 2013, and relevant Rules made thereunder secretarial@metropolisindia.com What’s Inside 02-29 Investor Information Corporate Overview ` 8,993 crore. Approx. 02 Maximising Capabilities. Amplifying Growth. 04 FY26 Key Highlights Market Capitalisation as of 06 TruHealth March 31, 2026 08 Specialty Diagnostics 10 Metropolis at a Glance 542650 12 Geographic Presence BSE Code 14 Journey 16 Awards and Accolades METROPOLIS 18 Board of Directors NSE Symbol 19 Leadership Team 20 Letter from the Chairperson METROHL.IN 26 Message from the Managing Director Bloomberg Code 30-79 Integrated Report August 18, 2026 30 Value Creation Model AGM Date 32 Strategy 34 Stakeholder Engagement Video Conferencing 36 Financial Capital AGM Mode 38 Intellectual Capital 50 Service Capital 56 Human Capital Forward-looking 64 ESG at Metropolis Statements 66 Natural Capital This report includes forward- 68 Social & Relationship Capital looking statements relating to 76 Governance Metropolis Healthcare Limited’s 79 Corporate Information future plans, strategies, and 80-192 expected performance. These are based on current assumptions, Statutory Reports industry trends, and regulatory 80 Management Discussion and Analysis frameworks, and are subject to 97 Business Responsibility and Sustainability Report uncertainties and risks beyond 135 Board's Report the Company’s control. Actual 162 Corporate Governance Report results may differ materially due 193-364 to factors such as changes in healthcare regulations, market Financial Statements dynamics, or unforeseen events. 193 Standalone Financial Statements Metropolis does not undertake to 282 Consolidated Financial Statements update these statements unless required by applicable law. 365-378 Notice 365 Notice Or scan the QR code below to view this report and To access detailed investor-related information quarterly results online. and periodic updates, please visit: https://www.metropolisindia.com/investors Annual Report 2025-26 Maximising Capabilities. Amplifying Growth. For over four decades, FY26 marked an important Metropolis Healthcare milestone in our journey. has earned the trust of clinicians, hospitals Building on the strong foundations established over the past few years, we shifted our focus and patients through from expanding capabilities to maximising scientific excellen [Showing first 8,000 characters — download PDF for full document]